PITTSBORO, NC -- (MARKET WIRE) -- May 01, 2007 -- Biolex Therapeutics today announced a strategic collaboration with Merial Limited, a world-leader in animal health, for the development of animal health products using Biolex’s patented LEX System(SM). The collaboration will leverage key advantages of the LEX System to provide Merial with high quality vaccine antigens. Merial is a joint venture between Merck & Co., Inc. and sanofi-aventis.
